HCT 0.00% 0.9¢ holista colltech limited

Media Write Up - Good Read

  1. 3,581 Posts.
    lightbulb Created with Sketch. 187
    https://www.newsmaker.com.au/news/376822/pathawayr-active-ingredient-in-plantbased-alcoholfree-natshieldtm-hand-sanitiser-developed-by-holista-colltech-tested-9999-effective-against-covid19-surrogate#.Xp9WpWYza70


    Above is the media write up, a very good read especially this paragraph below which I have highlighted :

    The feline coronavirus is increasingly used in international testing as a surrogate to COVID-19 as there are huge bio-security and safety concerns for laboratories handling the actual virus. In line with regulations of Australia's Therapeutic Goods Administration, claims of efficacy against COVID-19 as a disinfectant must be made with surrogate human or animal coronaviruses including the feline coronavirus. The U.K. laboratory tested Path-Away(R) against the feline coronavirus (Realm: Riboviria; Order: Nidovirales; Family: Coronaviridae; Genus: Betacoronavirus; Species: COVID-19).
 
watchlist Created with Sketch. Add HCT (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $2.509M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $351 39K

Buyers (Bids)

No. Vol. Price($)
2 186265 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 464347 5
View Market Depth
Last trade - 10.11am 24/07/2024 (20 minute delay) ?
HCT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.